Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Letters

Response to “Clarification from the College of Physicians and Surgeons of BC on commentary about limitations of the CDC guideline for prescribing opioids”

Jason W. Busse, David Juurlink and Gordon H. Guyatt
CMAJ April 03, 2017 189 (13) E509; DOI: https://doi.org/10.1503/cmaj.732910
Jason W. Busse
Michael G. DeGroote Institute for Pain Research and Care, Departments of Anesthesia and Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Juurlink
Departments of Medicine and Paediatrics, University of Toronto, Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gordon H. Guyatt
Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

We appreciate Dr. Oetter’s feedback1 on our commentary.2 The announcement by the College of Physicians and Surgeons of British Columbia regarding their new prescribing standards states:

Many of the principles contained in the new standard reflect the US Centers for Disease Control and Prevention’s (CDC) Guideline for Prescribing Opioids for Chronic Pain — United States 2016, which the Board endorsed in April 2016.3

The college’s fourth standard (https://www.cpsbc.ca/files/pdf/PSG-Safe-Prescribing.pdf), also a recommendation by the CDC guideline, directs physicians to prescribe opioids at doses not exceeding 90 mg of morphine or equivalent (MME) per day except in cases of “exceptional need and benefit,” excluding treatment with methadone.

With no clear definition of what constitutes exceptional need and benefit, a physician might abruptly reduce prescribed doses simply to comply with this regulatory standard. A survey conducted by the Boston Globe and Inspire, an American health care social network of 200 online support groups with 800 000 members, found that nearly two-thirds of respondents reported that acquiring prescribed opioid medication had become more difficult in the past year. When asked why, 26% advised that their doctors had stopped prescribing opioids and another 15% reported that their physicians had decreased their doses.4

Some patients will find withdrawal from opioids to be intolerable and one option to mitigate symptoms is to seek illicit opioids. Maria Hudspith, executive director of Pain BC, has reported that her organization is hearing from concerned pain sufferers who no longer have access to opioids, and are turning to the streets to acquire them.5

Notwithstanding Dr. Oetter’s point regarding the flexibility allowed a physician based on his or her judgment, we believe that more specific guidance is needed to guard against harms associated with opioid reduction and withdrawal, particularly for patients using high-dose opioids. We submit for consideration our ninth draft recommendation from the updated Canadian guideline for opioids and chronic non-cancer pain (currently available for public review and comment: http://nationalpaincentre.mcmaster.ca).

Recommendation #9: For patients with chronic non-cancer pain currently using 90 mg morphine equivalents of opioids per day or more, we suggest tapering opioids to the lowest possible dose, including discontinuation, rather than no change in opioid therapy (Weak recommendation, Low quality evidence).

Associated remark: Some patients are likely to experience significant increase in pain or decrease in function that persist more than one month after a small dose reduction; tapering may be paused and potentially abandoned in such patients.

Associated rationale: Reduction in opioid dose may reduce adverse effects including cognitive impairment and the likelihood of non-fatal or fatal unintentional overdose. Reduction, particularly if not done very slowly, may cause increased pain, decreased function, or highly aversive symptoms of opioid withdrawal.

We encourage the College of Physicians and Surgeons of British Columbia to consider expanding its standards to provide explicit guidance of this sort, including the option for tapering to be paused or abandoned based on a patient’s response.

Footnotes

  • Competing interests: All of the authors are members of the guideline development group for the Canadian Guideline for Safe and Effective Use of Opioids for Chronic Non-Cancer Pain. David Juurlink was a member of the Stakeholder Review Group for the CDC Guideline for Prescribing Opioids for Chronic Pain. No other competing interests were declared.

References

  1. ↵
    1. Oetter HM
    . Clarification from the College of Physicians and Surgeons of BC on commentary about limitations of the CDC guideline for prescribing opioids [letter]. CMAJ 2017;189:E508.
    OpenUrlFREE Full Text
  2. ↵
    1. Busse JW,
    2. Juurlink D,
    3. Guyatt GH
    . Addressing the limitations of the CDC guideline for prescribing opioids for chronic noncancer pain. CMAJ 2016; 188:1210–1.
    OpenUrlFREE Full Text
  3. ↵
    College Board adopts new professional standard on safe prescribing to address public health emergency related to opioid overdoses [media release]. Vancouver: College of Physicians and Surgeons of British Columbia; 2016 June 1. Available: https://www.cpsbc.ca/files/pdf/2016-06-01-Board-Adopts-New-Standard-on-Safe-Prescribing.pdf (accessed 2017 Feb. 11).
  4. ↵
    1. Freyer FJ
    . Strict opioids laws hit chronic pain sufferers hard. Boston Globe and Inspire 2016 June 16. Available: https://www.bostonglobe.com/metro/2016/06/18/the-other-side-america-war-opioids/i9YYLR0bGWFdP9z1T1pwjI/story.html (accessed 2017 Feb. 11).
  5. ↵
    1. Meuse M
    . Pain sufferers turning to street drugs as B.C. doctors prescribe fewer opioids. CBC News 2016 July 19. Available: www.cbc.ca/news/canada/british-columbia/opioid-prescriptionreluctance-1.3685377 (accessed 2017 Feb. 11).
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 189 (13)
CMAJ
Vol. 189, Issue 13
3 Apr 2017
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Response to “Clarification from the College of Physicians and Surgeons of BC on commentary about limitations of the CDC guideline for prescribing opioids”
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Response to “Clarification from the College of Physicians and Surgeons of BC on commentary about limitations of the CDC guideline for prescribing opioids”
Jason W. Busse, David Juurlink, Gordon H. Guyatt
CMAJ Apr 2017, 189 (13) E509; DOI: 10.1503/cmaj.732910

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Response to “Clarification from the College of Physicians and Surgeons of BC on commentary about limitations of the CDC guideline for prescribing opioids”
Jason W. Busse, David Juurlink, Gordon H. Guyatt
CMAJ Apr 2017, 189 (13) E509; DOI: 10.1503/cmaj.732910
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Footnotes
    • References
  • Responses
  • Metrics
  • PDF

Related Articles

  • Clarification from the College of Physicians and Surgeons of BC on commentary about limitations of the CDC guideline for prescribing opioids
  • PubMed
  • Google Scholar

Cited By...

  • The authors respond to "The 2017 Canadian opioid guideline: already time for an overhaul"
  • Google Scholar

More in this TOC Section

  • Virtual care and emergency department use
  • The denial of racism is racism itself
  • An expanded role for blood donor emerging pathogens surveillance
Show more Letters

Similar Articles

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire